ArticleJCEM case reports2025
Advanced Magnetic Resonance Imaging Techniques for Localization of a Small Thyrotropin-Secreting Pituitary Tumor.
Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyrotropin (TSH)-secreting pituitary tumors (TSH-omas) are a rare cause of hyperthyroidism. Historically, the majority have been macroadenomas (>1 cm); however, microadenomas (<1 cm) are increasing in frequency. Localization of TSH-secreting microadenomas can be challenging. We report the first case employing advanced pituitary magnetic resonance imaging (MRI) sequences to localize a TSH-secreting microadenoma, leading to successful resection. The patient presented with mild symptoms of hyperthyroidism and biochemistry confirming secondary hyperthyroidism. α-Glycoprotein subunit and sex hormone-binding globulin were elevated; however, cross-linked C-telopeptide of type I collagen was within the reference range. No pathogenic variants in thyroid hormone resistance genes were detected. A triiodothyronine suppression test, thyroid hormone-releasing hormone stimulation test, and short-acting octreotide suppression test were consistent with a TSH-oma. Initial pituitary MRI did not demonstrate a pituitary tumor. However, advanced imaging techniques including coronal T1 3-dimensional volumetric interpolated breath-hold sequence (VIBE) thin-slice scans confirmed a small, right-sided pituitary tumor. Transsphenoidal surgery was performed, and histopathology confirmed a TSH-oma. The patient remains in biochemical remission. TSH-secreting microadenomas are increasing in frequency and localization is likely to become an increasing challenge. Advanced MRI imaging techniques appear beneficial in the localization of TSH-secreting microadenomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.